Research Topics
| S LeiblSummaryAffiliation: Medical University of Graz Country: Austria Publications
|
Detail Information
Publications
How many lymph nodes are necessary to stage early and advanced adenocarcinoma of the sigmoid colon and upper rectum?Sebastian Leibl
University of Graz, School of Medicine, Auenbruggerplatz 25, 8036 Graz, Austria
Virchows Arch 443:133-8. 2003....
Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markersSebastian Leibl
Department of Pathology, Medical University of Graz, Graz, Austria
Am J Surg Pathol 29:347-53. 2005..CD29 and 14-3-3sigma represent valuable novel myoepithelial markers in these diagnostically difficult cases...
Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?S Leibl
Department of Pathology, Medical University of Graz, Auenbruggerplatz 25, A 8036 Graz, Austria
J Clin Pathol 58:700-4. 2005..Metaplastic carcinomas (MCs) of the breast rarely express steroid receptors and Her-2, which minimises the options for adjuvant treatment in patients with advanced disease...
Flat epithelial atypia (DIN 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasiaS Leibl
Institute of Pathology, Medical University of Graz, Graz, Austria
Histopathology 50:859-65. 2007..The aim of this study was to determine its biological significance as an incidental finding in breast biopsy specimens...
Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiationSebastian Leibl
Institute of Pathology, Medical University of Graz, Graz, Austria
Am J Surg Pathol 30:450-6. 2006..The immunophenotype of NOS-type sarcomas with CD10 expression suggests that these neoplasms represent a mammary sarcoma variant with myoepithelial features...
Mammary and extramammary Paget's disease: an immunohistochemical study of 83 casesB Liegl
Department of Pathology, Medical University of Graz, Graz, Austria
Histopathology 50:439-47. 2007..The aim of this study was, by the use of immunohistochemistry, to derive further information about the cell(s) of origin, find a diagnostically useful immunohistochemical panel and investigate candidates for possible targeted therapy...
Malignant transformation within benign adnexal skin tumoursB Liegl
Institute of Pathology, Medical University of Graz, Graz, Austria
Histopathology 45:162-70. 2004..Therefore, patients with systemic diseases or malignancy should be carefully examined and followed for sudden changes in pre-existing benign cutaneous tumours...
EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphologySebastian Leibl
Department of Pathology, Medical University of Graz, Graz, Austria
APMIS 116:27-32. 2008..Since UCs with metaplastic morphology have been shown to be more resistant to conventional radiotherapy or chemotherapy, the strikingly strong EGFR expression in these tumours may offer a new perspective for affected patients...
Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progressionCord Langner
Institute of Pathology, Medical University Graz, Auenbruggerplatz 25, Graz, Austria
Virchows Arch 448:325-30. 2006..001) to be independent predictors of patient outcome. In conclusion, AMACR expression correlated with advanced tumour stage and grade and may serve as an additional prognostic indicator in upper urinary tract urothelial cancer...
Metaplastic sarcomatoid carcinoma of the breast: not a misnomerSebastian Leibl
Am J Surg Pathol 30:1052-3; author reply 1053-5. 2006
Ovarian granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: An immunohistochemical studySebastian Leibl
Department of Pathology, Medical University of Graz, Auenbruggerplatz 25, A-8036 Graz, Austria
Gynecol Oncol 101:18-23. 2006..These findings provide some evidence to further explore the potential use of agents targeting these receptors (particularly EGFR) in the treatment of ovarian GCTs...
